Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for INNOCARE?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2017–2025
Financial statements are reported in CNY, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from CN¥102000 in FY2017 to CN¥2.37B in FY2025 (8-year CAGR +251.5%).
- Net income was negative in FY2017, FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024.
- Operating cash flow was below half of net income in FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (CNY B) | 1.04 | 0.63 | 0.74 | 1.01 | 2.37 |
| YoY | 76368.7% | -40.0% | 18.1% | 36.7% | 135.3% |
| Net Income (CNY B) | -0.06 | -0.89 | -0.63 | -0.44 | 0.64 |
| Operating Cash Flow (CNY B) | 0.17 | -0.57 | -0.67 | -0.37 | 0.08 |
| ROE | -1.5% | -13.4% | -8.6% | -6.4% | 8.9% |
| Gross Margin | 93.7% | 77.1% | 82.6% | 86.3% | 92.0% |
| Net Margin | -6.2% | -141.8% | -85.5% | -43.7% | 27.1% |
| Debt-to-Assets | 23.5% | 25.9% | 27.6% | 28.3% | 28.4% |
Show all 9 fiscal years
| Fiscal Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (CNY B) | 0.00 | 0.00 | 0.00 | 0.00 | 1.04 | 0.63 | 0.74 | 1.01 | 2.37 |
| YoY | — | 1485.3% | -22.9% | 9.4% | 76368.7% | -40.0% | 18.1% | 36.7% | 135.3% |
| Net Income (CNY B) | -0.34 | -0.55 | -2.14 | -0.39 | -0.06 | -0.89 | -0.63 | -0.44 | 0.64 |
| Operating Cash Flow (CNY B) | -0.05 | -0.02 | -0.08 | -0.17 | 0.17 | -0.57 | -0.67 | -0.37 | 0.08 |
| ROE | — | — | — | -12.6% | -1.5% | -13.4% | -8.6% | -6.4% | 8.9% |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 93.7% | 77.1% | 82.6% | 86.3% | 92.0% |
| Net Margin | -335033.3% | -34010.5% | -171723.2% | -28694.6% | -6.2% | -141.8% | -85.5% | -43.7% | 27.1% |
| Debt-to-Assets | 465.0% | 138.1% | 212.7% | 30.4% | 23.5% | 25.9% | 27.6% | 28.3% | 28.4% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
-
Watch
Cash ConversionFinancial Quality
OCF / Net Income: FY2025 (2025-12-31) 0.13
FY2025 (ended 2025-12-31) · What is this?
-
Watch
Profit WarningMaterial Events
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
No dividends paid over the trailing 12 months.
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.